Neostigmine Bromide is a reversible acetylcholinesterase inhibitor in the carbamate class, primarily prescribed for the treatment of myasthenia gravis, Ogilvie syndrome, and urinary retention. By preventing… Read more
Neostigmine Bromide is a reversible acetylcholinesterase inhibitor in the carbamate class, primarily prescribed for the treatment of myasthenia gravis, Ogilvie syndrome, and urinary retention. By preventing the breakdown of acetylcholine at cholinergic synapses, this medication enhances neuromuscular transmission. Analytical laboratories utilize these Neostigmine Bromide reference standards, including pharmacopeial and non-pharmacopeial impurities like 2-(dimethylamino)cyclohexa-2,5-diene-1,4-dione, to ensure rigorous quality control and accurate impurity profiling. Stable isotope labelled compounds are also essential for method validation and serving as internal standards in complex mass spectrometry assays. Providing high-quality reference materials for both the active pharmaceutical ingredient and its associated degradation products and synthetic impurities supports compliance with regulatory requirements throughout the drug development lifecycle and ongoing stability testing protocols.